术前贫血与输血:心脏手术不良结局的罪魁祸首是谁?
该研究纳入19个心脏外科中心2007年1月至2017年12月间33,411例初次孤立冠状动脉旁路移植术患者,采用分层逻辑回归分析术前血细胞比容(Hct)与浓缩红细胞(PRBC)输血对术后结局的相对关联。结果显示,PRBC输血与术后死亡(OR 4.3)、肾衰竭(OR 6.3)和卒中(OR 2.4)的关联强于Hct值;术前贫血与PRBC输血概率增加达4倍、肾衰竭增加3倍及死亡风险几乎翻倍相关。
要点
- PRBC输血与术后死亡、肾衰竭和卒中的风险调整关联强于术前Hct值。
- 术前Hct每升高1个点,死亡概率降低(OR 0.97),肾衰竭概率降低(OR 0.94)。
- 术前贫血与PRBC输血概率增加达4倍、肾衰竭增加3倍及死亡风险几乎翻倍相关。
核心结论
- PRBC输血与风险调整后术后并发症和死亡的关联比术前Hct水平更密切,支持减少不必要的PRBC输血。
- 术前贫血独立增加术后并发症和死亡风险。
- 作者认为术前Hct应纳入STS风险计算器,优化术前Hct应作为潜在可改变危险因素进行研究。
研究设计与样本
- 研究纳入2007年1月至2017年12月在19个心脏外科中心进行的初次孤立CABG手术患者记录,共33,411例。
- 采用分层逻辑回归模型估计基线术前Hct水平及PRBC输血与术后死亡和并发症可能性的关系,并校正基线患者风险。
- 比较变量和模型性能特征以确定Hct水平与PRBC输血和主要结局的相对关联强度。
主要发现
- 患者中位年龄65岁(四分位距[IQR] 57-72岁),女性占26%。
- 术前Hct中位值为39%(IQR 36%-42%),STS预测死亡风险均值为1.8±3.1%。
- 并发症包括PRBC输血占31%、肾衰竭占2.8%、卒中占1.3%、手术死亡占2.0%。
- 术前Hct值与PRBC输血可能性之间观察到强关联(P < .001)。
- 风险调整后,PRBC输血而非Hct值与术后死亡(OR 4.3;P < .0001)、肾衰竭(OR 6.3;P < .0001)和卒中(OR 2.4;P < .0001)显示更强关联。
关键数值与推荐
- 术前Hct值与PRBC输血可能性强关联(P < .001)。
- PRBC输血与术后死亡关联的OR为4.3(P < .0001)。
- PRBC输血与肾衰竭关联的OR为6.3(P < .0001)。
- PRBC输血与卒中关联的OR为2.4(P < .0001)。
- 术前Hct每增加1个点与死亡关联的OR为0.97(P = .0001),与肾衰竭关联的OR为0.94(P < .0001)。
临床怎么用
- 作者认为应努力减少不必要的PRBC输血。
- 作者建议将术前Hct纳入STS风险计算器。
- 作者认为应研究优化术前Hct作为死亡和并发症的潜在可改变危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reducing blood product utilization after cardiac surgery has become a focus of perioperative care as studies have suggested improved outcomes. The relative impact of preoperative anemia versus packed red blood cells (PRBC) transfusion on outcomes remains poorly understood, however. In this study, we investigated the relative association between preoperative hematocrit (Hct) level and PRBC transfusion on postoperative outcomes after coronary artery bypass grafting (CABG) surgery. METHODS: Patient records for primary, isolated CABG operations performed between January 2007 and December 2017 at 19 cardiac surgery centers were evaluated. Hierarchical logistic regression modeling was used to estimate the relationship between baseline preoperative Hct level as well as PRBC transfusion and the likelihoods of postoperative mortality and morbidity, adjusted for baseline patient risk. Variable and model performance characteristics were compared to determine the relative strength of association between Hct level and PRBC transfusion and primary outcomes. RESULTS: A total of 33,411 patients (median patient age, 65 years; interquartile range [IQR], 57-72 years; 26% females) were evaluated. The median preoperative Hct value was 39% (IQR, 36%-42%), and the mean Society of Thoracic Surgeons (STS) predicted risk of mortality was 1.8 ± 3.1%. Complications included PRBC transfusion in 31% of patients, renal failure in 2.8%, stroke in 1.3%, and operative mortality in 2.0%. A strong association was observed between preoperative Hct value and the likelihood of PRBC transfusion (P < .001). After risk adjustment, PRBC transfusion, but not Hct value, demonstrated stronger associations with postoperative mortality (odds ratio [OR], 4.3; P < .0001), renal failure (OR 6.3; P < .0001), and stroke (OR, 2.4; P < .0001). A 1-point increase in preoperative Hct was associated with decreased probabilities of mortality (OR, 0.97; P = .0001) and renal failure (OR, 0.94; P < .0001). The models with PRBC had superior predictive power, with a larger area under the curve, compared with Hct for all outcomes (all P < .01). Preoperative anemia was associated with up to a 4-fold increase in the probability of PRBC transfusion, a 3-fold increase in renal failure, and almost double the mortality. CONCLUSIONS: PRBC transfusion appears to be more closely associated with risk-adjusted morbidity and mortality compared with preoperative Hct level alone, supporting efforts to reduce unnecessary PRBC transfusions. Preoperative anemia independently increases the risk of postoperative morbidity and mortality. These data suggest that preoperative Hct should be included in the STS risk calculators. Finally, efforts to optimize preoperative hematocrit should be investigated as a potentially modifiable risk factor for mortality and morbidity.
引用
- LaPar DJ, Hawkins RB, McMurry TL, et al. Preoperative anemia versus blood transfusion: Which is the culprit for worse outcomes in cardiac surgery? J Thorac Cardiovasc Surg. 2018. PMID: 29706372. doi:10.1016/j.jtcvs.2018.03.109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。